I am a final year PhD candidate in biomedical sciences with a focus on advancing microRNA-based therapeutics for drug-resistant Hepatocellular Carcinoma (HCC). Throughout my journey, I have harnessed cutting-edge technologies, including conducting microRNA-lethal screenings with a library of 2600 human microRNA mimic libraries across three distinct HCC cell lines. My research interests lie at the intersection of cancer metabolism, strategies to overcome cancer drug resistance, and the exciting potential of RNA therapeutics in the treatment landscape. I am passionate about translating scientific innovation into impactful solutions to combat drug resistance and enhance the efficacy of cancer treatments.